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In Fig. 6 B of this article, we reported that bacterially expressed His6-CLASP2(340–875) does not bind micro-
tubules in vitro. However, we found in subsequent experiments that the band on the immunoblot we interpreted as
His6-CLASP2(340–875) is in reality a bacterial contamination of very similar molecular mass, which is unfortunately
recognized by the antibody used in this experiment. We further found that we were not able to obtain sufficient
amounts of nondegraded recombinant His6-CLASP2(340–875) from bacteria to accurately compare its microtubule
binding to the longer construct. To resolve this, we instead cloned and expressed a shorter CLASP2 construct,
His6-CLASP2(340–650), which contains the entire NH
 
2
 
-terminal region sufficient for plus end tracking in cells.
We then repeated the microtubule-binding experiment and probed the immunoblot with a His-tag antibody (H-15;
Santa Cruz Biotechnology, Inc.) and now find that both constructs, His6-CLASP2(340–1084), which associates
with microtubule lattices in the cell periphery, and His6-CLASP2(340–650), which can only track plus ends in cells,
bind to microtubules in vitro with similar high affinity (K
 
D
 
 
 
 
 
 0.2 
 
 
 
M) within the accuracy of the microtubule pelleting
assay. S, supernatant; P, pellet. Molecular masses are indicated in kilodaltons on the right. Thus, contrary to our earlier
conclusion, the region between amino acids 875 and 1084 appears not to be directly required for high affinity microtubule
binding. Interestingly, this also suggests that microtubule plus end tracking in cells is not due to an inherently lower
affinity for microtubules as compared to classical lattice-binding microtubule-associated proteins. This does not affect
any of the other results reported in this paper.